Table 3 Association between metformin plus sodium-glucose transporter 2 inhibitors and metformin plus insulin and study outcomes after propensity score matching
Outcomes | Treatment groups | McNemar test | ||
|---|---|---|---|---|
Metformin + SGLT-2i (n = 34) | Other GLD (n = 34) | p value | ||
In-hospital deaths | 6 (17.6%) | 10 (29.4%) | 0.391 | 1.000 |
ICU admission, mechanical ventilation, or in-hospital death | 10 (29.4%) | 11 (32.4%) | 0.987 | 0.965 |
In-hospital complications | 19 (55.9%) | 22 (64.7%) | 0.620 | 0.201 |
Long-time hospital stay | 6 (17.6%) | 4 (11.8%) | 0.732 | 0.838 |
Metformin + insulin (n = 67) | Other GLD (n = 67) | p value | ||
In-hospital deaths | 24 (35.8%) | 23 (34.3%) | 1.000 | 0.521 |
ICU admission, mechanical ventilation, or in-hospital death | 46 (68.7%) | 36 (53.7%) | 0.112 | 0.111 |
In-hospital complications | 44 (65.7%) | 36 (53.7%) | 0.218 | 0.480 |
Long-time hospital stay | 15 (22.4%) | 13 (19.4%) | 0.832 | 0.870 |